
Loading, please wait...

Loading, please wait...

Union Health Minister J.P. Nadda recently addressed concerns regarding the India Rabies Vaccine Supply. He confirmed that the nation maintains an adequate inventory of Anti-Rabies Vaccine (ARV) and Rabies Immunoglobulin (RIG). Consequently, current production levels significantly exceed the annual domestic demand for these life-saving treatments.
Minister Nadda highlighted that India possesses an annual production capacity of approximately 8.17 crore vials of ARV. Additionally, manufacturers produce about 1.77 crore vials of RIG each year. However, the annual requirement is considerably lower. Specifically, India records around 58 lakh animal bite cases annually, including 47 lakh dog bites. Therefore, the country maintains a massive surplus and continues to export these vaccines globally.
State governments hold the primary responsibility for distributing vaccines within their regions. Under the National Rabies Control Programme (NRCP), the central government provides necessary technical and financial support. Furthermore, the National Health Mission (NHM) allocates funds to ensure an uninterrupted supply chain. Moreover, a real-time tracking system helps officials monitor stocks effectively across all states. The Ministry also issues regular advisories to prevent any potential local shortages. Because rabies is a fatal virus, the government prioritizes immediate access to post-exposure prophylaxis.
Q1: Is there a shortage of anti-rabies vaccines in India?
No. Union Health Minister J.P. Nadda confirmed that India has a surplus of both ARV and RIG, with production far outstripping domestic needs.
Q2: Who is responsible for vaccine distribution in India?
Health is a state subject. Therefore, individual state and UT governments manage the procurement and distribution of these vaccines using central funds.
Q3: How many animal bite cases are reported in India annually?
India reports approximately 58 lakh animal bite cases per year. Dog bites account for about 47 lakh of these total cases.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


J.P. Nadda confirms India Rabies Vaccine Supply is stable. Annual production of 8.17 crore vials far exceeds the demand from 58 lakh animal bite cases....
5 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today